Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Tinea Pedis Pipeline Drugs Market Report Overview
Athlete’s foot, also known as tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on the soles of the feet, unpleasant foot odor, and small itchy bubbles or blisters on the soles of the feet. Treatment includes antifungal medicines.
The tinea pedis pipeline products market research report provides comprehensive information on the therapeutics under development for tinea pedis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for tinea pedis and features dormant and discontinued projects.
Tinea Pedis Pipeline Products Market Segmentation by Targets
The key target in the tinea pedis pipeline products market is squalene monooxygenase.
Tinea Pedis Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanism of action in the tinea pedis pipeline products market is the squalene monooxygenase inhibitor.
Tinea Pedis Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the tinea pedis pipeline products market are topical and cutaneous. Topical accounted for the highest number of tinea pedis drugs in development in terms of RoA, in 2022.
Tinea Pedis Pipeline Products Market Analysis by Routes of Administration
For more RoA insights into the tinea pedis pipeline products market, download a free report sample
Tinea Pedis Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the tinea pedis pipeline products market are biologic and small molecule.
Tinea Pedis Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the tinea pedis pipeline products market, download a free report sample
Tinea Pedis Pipeline Products Market - Competitive Landscape
Some of the leading companies in the tinea pedis pipeline products market are DermBiont Inc, Blueberry Therapeutics Ltd, SaNOtize Research and Development Corp, and Taro Pharmaceuticals USA Inc. DermBiont Inc have the highest number of products in the tinea pedis pipeline products market in 2022.
Tinea Pedis Pipeline Products Market Analysis by Companies
To know more about the leading tinea pedis pipeline products market players, download a free report sample
Tinea Pedis Pipeline Products Market Overview
Key Targets | Squalene Monooxygenase |
Key MoA | Squalene Monooxygenase Inhibitor |
Key RoA | Topical and Cutaneous |
Key Molecule Type | Biologic and Small Molecule |
Leading Companies | DermBiont Inc, Blueberry Therapeutics Ltd, SaNOtize Research and Development Corp, and Taro Pharmaceuticals USA Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Tinea Pedis (Athlete Foot) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Tinea Pedis (Athlete Foot) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Tinea Pedis (Athlete Foot) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Tinea Pedis (Athlete Foot) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Tinea Pedis (Athlete Foot) (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for tinea pedis.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the tinea pedis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
DermBiont Inc
SaNOtize Research and Development Corp
Taro Pharmaceuticals USA Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the tinea pedis pipeline products market?
The key target in the tinea pedis pipeline products market is squalene monooxygenase.
-
What are the key mechanisms of action in the tinea pedis pipeline products market?
The key mechanism of action in the tinea pedis pipeline products market is the squalene monooxygenase inhibitor.
-
What are the key routes of administration in the tinea pedis pipeline products market?
The key routes of administration in the tinea pedis pipeline products market are topical and cutaneous.
-
What are the key molecule types in the tinea pedis pipeline products market?
The key molecule types in the tinea pedis pipeline products market are biologic and small molecule.
-
Which are the leading companies in the tinea pedis pipeline products market?
Some of the leading companies in the tinea pedis pipeline products market are DermBiont Inc, Blueberry Therapeutics Ltd, SaNOtize Research and Development Corp, and Taro Pharmaceuticals USA Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.